Related Experiment Video
Updated: Aug 4, 2025

11:47
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
10.6K
Dimercaptosuccinic Acid: Summary of Evidence
Jamarius Carvin1,2, Tara Thompson3
1Mercer University, Macon, Georgia.
International Journal of Pharmaceutical Compounding
|March 31, 2023
Summary
Dimercaptosuccinic acid (succimer) is an oral chelating agent primarily for lead poisoning. Emerging data suggests efficacy for mercury and arsenic poisoning, broadening its therapeutic potential.
Area of Science:
- Toxicology
- Pharmacology
- Environmental Health
Background:
- Heavy-metal poisoning poses significant health risks.
- Dimercaptosuccinic acid (succimer) is an established oral chelating agent.
- Lead intoxication is the primary indication for succimer treatment.
Purpose of the Study:
- To review the role of dimercaptosuccinic acid as a chelating agent.
- To provide general information on dimercaptosuccinic acid's applications.
- To highlight emerging uses in mercury and arsenic poisoning.
Main Methods:
- Literature review of dimercaptosuccinic acid's chelating properties.
- Analysis of clinical data on succimer for heavy-metal poisoning.
- Synthesis of information on succimer's mechanism and efficacy.
Main Results:
- Dimercaptosuccinic acid effectively chelates lead.
- Initial studies indicate succimer's potential in treating mercury poisoning.
- Encouraging results are observed for arsenic poisoning treatment with succimer.
Conclusions:
- Dimercaptosuccinic acid is a valuable therapeutic agent for heavy-metal poisoning.
- Succimer shows promise beyond lead intoxication, including mercury and arsenic.
- Further research may expand succimer's clinical utility in toxicology.

